(firstQuint)A Study of Oral Dosing of ASP0456 in Patients With Chronic Constipation.

 This study consists of two parts.

 In Part I, ASP0456 or placebo will be administered orally in a blind manner.

 In Part II, the long-term safety and efficacy of ASP0456 will be evaluated in patients who have participated in the study and completed the Part I.

.

 A Study of Oral Dosing of ASP0456 in Patients With Chronic Constipation@highlight

The objective of this study is to verify the efficacy and investigate the safety of the study drug when ASP0456 is administered orally for 4 weeks and 52 weeks.

